Ophthalmology near Elmhurst, NY

Care Philosophy: The gift of sight is one of the most cherished and treasured of all our senses. Whether it's macular degeneration, diabetic eye disease, retinal detachment, retinal vein occlusion or ocular inflammation, I offer a caring and nurturing environment for patients and their families during such a vulnerable and uncertain time. I strive to deliver the most compassionate medical and surgical care using the latest state-of-the-art diagnostic and treatment technology to provide an individualized treatment regimen based on a strong scientific and evidenced-based foundation. My patients come from all walks of life and from every corner of the world. Some patients and families come for a single visit seeking a second opinion, others have been coming practically monthly for nearly ten years. I look forward to meeting you and meeting the challenges of caring for your eyesight.

Care Philosophy: While medical education and research are very rewarding, my primary focus is to provide thoughtful and compassionate individualized care. I pride myself on being approachable and caring, and do my best to provide understandable explanations to my patients. The patient and physician are a team - working together towards a common goal. I believe in sub-specialized medical care, and for that reason, confine my practice to the eyelids, orbit and lacrimal system.

Biography: Dr. Sangwoo Lee is a board certified Ophthalmology practicing at NewYork-Presbyterian Queens located in Fresh Meadows, NY. He received his medical degree from Warren Alpert Medical School at Brown University, completed his internship in Internal and residency in Ophthalmology at NewYork-Presbyterian Weill Cornell Medical Center. Following his residency he then completed his fellowship in Vitreo-retinal Disease and Surgery at NewYork-Presbyterian Weill Cornell Medical Center. Dr. Lee is certified by the American Board of Ophthalmology and is an Assistant Professor of Ophthalmology at Weill Medical College.Dr. Lee is the Medical Director of the Queens Eye Center and spearheads the retinal program at the Center. He has special interest in diabetic eye diseases, macular degeneration, retinal tears and retinal detachments. Dr. Lee experience in ocular trauma is critical to is work as team eye physician to the New York Mets.

Biography: Brian Marr, MD heads the Ophthalmic Oncology Service at the Harkness Eye Institute. He has comprehensive experience in the diagnosis, treatment, and management of ocular tumors including intraocular tumor resection, laser, radiation, and chemotherapy procedures. He has helped devise thousands of complex treatments for tumors of the eye, eyelid, orbit, and conjunctiva for his adult, children, and infant patients. Currently, Dr. Marr is a collaborator on a Columbia University clinical trial for a first-of-its-kind, new class of drug treatment for uveal melanoma. Dr. Marr is a board-certified ophthalmologist whose work has centered around ophthalmic oncology since 2000. One of the very few ocular oncologists trained in all aspects of eye cancer, Dr. Marr's clinical experience in treating these diseases is among the most extensive in the United States. His interest and experience in ophthalmic oncology began during an eight-year tenure in the Ocular Oncology Service at the Wills Eye Hospital in Philadelphia. There, he gained extensive experience treating intraocular tumors, and tumors of the eyelid, orbit, and conjunctiva in children and adults. It was there that Dr. Marr developed and improved many surgical procedures used to cure cancers of the eye, successfully treated thousands of patients, and helped their families though their battle with eye cancer. Next, Dr. Marr moved on to Memorial Sloan Kettering Cancer Center, where he remain for nine years, starting in 2008. Dr. Marr has some of the greatest experience with intra-arterial chemotherapy for treating retinoblastoma in the country, if not the world, as well as all other forms of retinoblastoma treatment. He has been a key member of many multidisciplinary surgical teams, treating advanced skull base tumors and complex facial skin lesions. He has developed a strong belief and treatment philosophy that the best research be used to help his patients, rather than his best patients be used to help his research. The field of ophthalmic oncology encompasses many rare conditions and his experience helps his patients get the best care and results as quickly as possible. Dr. Marr lectures and consults across the US and abroad, and has authored numerous research articles in the field of ocular oncology. He is the principal investigator in a first-in-class drug study for treating primary uveal melanoma, in an international, multi-center trial. He also volunteers his medical expertise in underserviced parts of the world, such as Nigeria and Indonesia, and has helped train physicians in more than 20 countries. Dr. Marr's efforts as a contributor to ongoing education in ocular oncology have been recognized by the American Academy of Ophthalmology, where he now serves as chief editor of the Academy's Oncology and Pathology's One network.